Sun et al. reported that an androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), interacts with obesity-induced pro-inflammatory signaling to promote NASH-related hepatocarcinogenesis. Here, AR is linked to metabolic dysfunction-associated steatohepatitis.